Frank McCormick - Chairman Oncology, Bridgebio Pharma, Inc

As of November 17, 2020


Frank McCormick Net Worth

  • Net worth is estimated to be at least $27.25M
  • Owns at least 1,200,468 units of Bridgebio Pharma, Inc stock
  • Sold an estimated value of $8.03M in the last year at Bridgebio Pharma, Inc

Frank McCormick Trading

  • Largest sale of shares was 100,000 units , worth over $4.28M on November 17, 2020
  • In total has made about 4 transactions over a year
  • Usually trades in May, November, December and July, with the busiest year in 2020 and 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Frank McCormick Mailing Address

  • Mailing address is C/o Exelixis Inc 170 Harbor Way S San Francisco CA 94083-0511 CA

Bridgebio Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Neil Kumar, Ph.D. 2020 $550,000 $825,000 $2,368,511 $6,299,998 $11,400 $10,054,909
Neil Kumar, Ph.D. 2019 $502,765 $360,000 $13,863,445 $11,573,049 $34,804 $26,334,063
Neil Kumar, Ph.D. 2018 $450,000 - - - - $450,000
Brian Stephenson, Ph.D., CFA 2020 $550,000 $712,500 $789,494 $2,099,996 $11,943 $4,163,933
Brian Stephenson, Ph.D., CFA 2019 $420,000 $189,000 $132,600 $3,430,781 $26,586 $4,198,967
Brian Stephenson, Ph.D., CFA 2018 $74,375 $330,240 $1,942,500 - - $2,347,115
Michael Henderson, M.D. 2020 $515,000 $300,000 $7,072,500 $91,899 $11,843 $7,991,241
Cameron Turtle, Ph.D.* 2020 $400,000 $210,000 $3,940,081 - $11,400 $4,561,482
Charles Homcy, M.D. 2020 $500,000 $100,000 - $1,199,992 $55,812 $1,855,805
Charles Homcy, M.D. 2019 $513,808 - $2,111,579 $3,128,716 $221,737 $5,975,842
Brian Stolz 2020 $511,362 $25,000 $736,854 $1,992,182 $1,975,453 $5,240,851
Brian Stolz 2019 $146,780 $93,750 $6,860,780 $1,045,003 - $8,146,313
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1743881/000119312521145491/d131567ddef14a.htm

Bridgebio Pharma, Inc Insider Trading

  • The most recent transaction was 10,000 units bought on January 6, 2022 by Douglas Dachille worth over $163.65K
  • In the last 3 years, insiders at Bridgebio Pharma, Inc sold an estimated value of $351.46M and bought an estimated value of $213.15M
  • The most active traders are Neil Kumar, CEO and President,  Thomas Michael Henderson, Chief Business Officer,  and Brian Stephenson, See Remarks
  • Insider trading is most common in June, with the busiest year in 2020

BridgeBio Pharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1